Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells-Reference-Cited by-同舟云学术

Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells

Published:2014-12-10 Issue:4 Volume:6 Page:2206-2221
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Cannito Stefania¹,Turato Cristian²,Paternostro Claudia¹,Biasiolo Alessandra²,Colombatto Sebastiano³,Cambieri Irene⁴,Quarta Santina²,Novo Erica¹,Morello Elisabetta¹,Villano Gianmarco²,Fasolato Silvano²,Musso Tiziana⁵,David Ezio⁶,Tusa Ignazia⁷,Rovida Elisabetta⁷,Autelli Riccardo¹,Smedile Antonina⁸,Cillo Umberto⁹,Pontisso Patrizia²,Parola Maurizio¹

Affiliation:

1. Department of Clinical and Biological Sciences, Unit of Experimental Medicine and Interuniversity Center for Liver Pathophysiology, University of Torino, Italy

2. Department of Medicine, University of Padova, Italy

3. Department of Oncology, University of Torino, Italy

4. Department of Plastic Surgery and Burn Unit Skin Bank, CTO Hospital, Torino, Italy

5. Department of Public Health and Pediatric Sciences, University of Torino, Italy

6. Pathology Unit, San Giovanni Battista Hospital, Torino, Italy

7. Department of Biomedical, Experimental and Clinical Sciences “Mario Serio”, University of Firenze, Italy

8. Gastroenterology and Hepatology Division, San Giovanni Battista Hospital, Torino, Italy

9. Unit of Hepatobiliary Surgery and Liver Transplantation, University of Padova, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SerpinB3: A Multifaceted Player in Health and Disease—Review and Future Perspectives;Cancers;2024-07-18

2. The protease activated receptor 2 - CCAAT/enhancer-binding protein beta - SerpinB3 axis inhibition as a novel strategy for the treatment of non-alcoholic steatohepatitis;Molecular Metabolism;2024-03

3. SERPINB3 in fibrogenic chronic liver diseases and primary liver cancers;Exploration of Digestive Diseases;2024-02-28

4. SERPINB3-MYC axis induces the basal-like/squamous subtype and enhances disease progression in pancreatic cancer;Cell Reports;2023-12

5. The polymorphic variant of SerpinB3 (SerpinB3‐PD) is associated with faster cirrhosis decompensation;Alimentary Pharmacology & Therapeutics;2023-11-21